Reference health
Inferring the Effects of Vertical Integration from Entry Games: An Analysis of the Generic Pharmaceutical Industry
1 of 49 checkable references need attention · checked 2026-08-28
At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.
15 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
References needing attention
does not resolve to a known work10.1162/105864097567039
The 48 checked references that resolve
resolves10.1162/0033553041502144
Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry
resolves10.1162/0033553042476152
Contractibility and Asset Ownership: On-Board Computers and Governance in U. S. Trucking
resolves10.2307/2534790
Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry
resolves10.1016/j.jhealeco.2005.04.008
The effect of physician–hospital affiliations on hospital prices in California
resolves10.1111/1467-6451.00166
Market size and vertical integration: Stigler’s hypothesis reconsidered
resolves10.3386/w13069
Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration
resolves10.1057/palgrave.jgm.4940048
M&A Strategy within the Generic Pharmaceuticals Sector: Vertical Integration into Active Pharmaceutical Ingredients
resolves10.1086/467257
Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act
resolves10.1086/261404
The Costs and Benefits of Ownership: A Theory of Vertical and Lateral Integration
resolves10.1111/j.1467-6451.2005.00266.x
MARKET POWER, VERTICAL INTEGRATION AND THE WHOLESALE PRICE OF GASOLINE*
resolves10.1057/palgrave.jgm.4940047
Global Generics Profitability: Increasing Need for Business Development and Licensing
resolves10.1086/514347
Cementing Relationships: Vertical Integration, Foreclosure, Productivity, and Prices
resolves10.3982/ecta6649
What Happens When Wal-Mart Comes to Town: An Empirical Analysis of the Discount Retailing Industry
resolves10.1377/hlthaff.20.5.241
Are The Benefits Of Newer Drugs Worth Their Cost? Evidence From The 1996 MEPS
resolves10.1016/j.ijindorg.2009.07.002
Predicting the impact of upstream mergers on downstream markets with an application to the retail gasoline industry
resolves10.2139/ssrn.950205
Vertical Mergers, Foreclosure and Raising Rivals' Costs - Experimental Evidence
resolves10.3386/w11431
Generic Scrip Share and the Price of Brand-Name Drugs: The Role of the Consumer
resolves10.1111/j.1756-2171.2006.tb00034.x
An empirical model of firm entry with endogenous product-type choices
resolves10.1057/palgrave.jgm.4950062
FTC Review of Generic Drug Mergers — Four Recent Consents Provide Significant Guidance on Mode of Analysis and Divestiture Requirements
resolves10.1057/palgrave.jgm.4940132
The Evolution of the Global Active Pharmaceutical Ingredients Supply Market and the Impact on the Generic Pharmaceuticals Business in the United States
resolves10.1016/j.ijindorg.2008.12.003
Market foreclosure and vertical merger: A case study of the vertical merger between Turner Broadcasting and Time Warner
resolves10.1111/1467-937x.00240
Incomplete Simultaneous Discrete Response Model with Multiple Equilibria
resolves10.1016/s0167-7187(01)00085-6
Non-contractible investments and vertical integration in the Mexican footwear industry
The 15 references without a DOI — listed, not checked
no DOI — not checkedWatson Sees Future in India
no DOI — not checkedref9
no DOI — not checkedThe Medical Expenditure Panel Survey: A National Health Information System
no DOI — not checkedVertical Integration in the Presence of Upstream Competition
no DOI — not checkedref24
no DOI — not checkedref34
no DOI — not checkedref38
no DOI — not checkedEquilibrium Vertical Foreclosure: Reply
no DOI — not checkedref43
no DOI — not checkedref45
no DOI — not checkedAnticompetitive Vertical Integration by a Dominant Firm
no DOI — not checkedEvaluating Vertical Mergers: A Post Chicago Approach
no DOI — not checkedMylan in India's Biggest Pharmaceutical Takeover as it Enters the Matrix
no DOI — not checkedEmpirical Studies of Vertical Foreclosure
no DOI — not checkedAnnual Report (Form 20-F). Financial statement
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-08-28 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2139/ssrn.1544883"><img src="https://citestamp.com/citestamped/10.2139/ssrn.1544883/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2139/ssrn.1544883)